Using infrared thermal imaging to evaluate angioplasty for peripheral artery disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of infrared thermal imaging (IRTI) in assessing blood perfusion in patients with peripheral artery disease (PAD) after undergoing percutaneous transluminal angioplasty (PTA). It aims to determine the success rate of the angioplasty procedure by monitoring changes in foot blood flow. The study focuses on patients with critical limb ischemia and varying degrees of arterial lesions, using IRTI as a follow-up tool post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with Rutherford grade 3, 4, 5, or 6.
* Patients with indications for lower extremity arterial PTA: severe intermittent claudication, rest pain, ulceration or gangrene.
* Patients who required PTA of only one limb (left versus right).

Exclusion Criteria:

* Patients with body temperature above 37 ° C.
* Patients with indications for open surgery.
* Patients requiring major amputation (above the ankle).
* Patients with acute occlusive or embolic limb ischemia.
* Patients with deep venous thrombosis of the lower extremity.

Where it's running

• Fangge Deng
  Guangzhou, Guangdong, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health for Hungary: Long-term blood and health data collection to study aging and disease onset

  This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.

  Recruiting at 21 sites Center for Molecular Fingerprinting Research Nonprofit LLC · Balatonfüred and 32 other locations · NCT07743021

• Reducing blood clots after leg artery procedures with Factor XI inhibitors in adults with PAD

  This trial tests two drugs, REGN7508 and REGN9933, to see if they lower the chance of dangerous blood clots after leg artery restoration procedures in adults with peripheral artery disease.

  Recruiting at 32 sites Phase 3 Regeneron Pharmaceuticals · Alexander City, Alabama and 31 other locations · NCT07318610

• Near-infrared light to map blood flow and muscle oxygen use in peripheral artery disease

  This project tries to use near-infrared light to measure blood flow and muscle oxygen use in people with peripheral artery disease and see if those measurements predict who will improve after vascular treatments.

  Recruiting The University of Texas at Arlington · Arlington, Texas and 1 other locations · NCT07313410

• Detecting lower‑leg peripheral artery disease using segmental pulse arrival time

  This trial will test whether measuring segmental pulse arrival time, and whether warming the skin or elevating the foot, can help detect lower‑leg peripheral artery disease in adults aged 19 and older.

  Recruiting University of Nebraska · Omaha, Nebraska · NCT07226193

• Algae supplements for heart risk markers and gut health

  This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.

  Recruiting Universidade do Porto · Porto · NCT07173062

• Six-minute stepper test for people with peripheral artery disease

  This project will test whether the six-minute stepper test can measure exercise ability in adults with peripheral artery disease.

  Recruiting Gazi University · Ankara, Çankaya · NCT07169045

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.